71 related articles for article (PubMed ID: 11806717)
1. Correlation of the antibacterial activities of cationic peptide antibiotics and cationic steroid antibiotics.
Ding B; Guan Q; Walsh JP; Boswell JS; Winter TW; Winter ES; Boyd SS; Li C; Savage PB
J Med Chem; 2002 Jan; 45(3):663-9. PubMed ID: 11806717
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of structurally related alpha-helical cationic antimicrobial peptides.
Scott MG; Yan H; Hancock RE
Infect Immun; 1999 Apr; 67(4):2005-9. PubMed ID: 10085049
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial Activity and Mechanism of Action of Bovine Lactoferricin Derivatives with Symmetrical Amino Acid Sequences.
Sun C; Li Y; Cao S; Wang H; Jiang C; Pang S; Hussain MA; Hou J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262770
[TBL] [Abstract][Full Text] [Related]
4. Targeted drug-carrying bacteriophages as antibacterial nanomedicines.
Yacoby I; Bar H; Benhar I
Antimicrob Agents Chemother; 2007 Jun; 51(6):2156-63. PubMed ID: 17404004
[TBL] [Abstract][Full Text] [Related]
5. Direct Antimicrobial Activity of IFN-β.
Kaplan A; Lee MW; Wolf AJ; Limon JJ; Becker CA; Ding M; Murali R; Lee EY; Liu GY; Wong GCL; Underhill DM
J Immunol; 2017 May; 198(10):4036-4045. PubMed ID: 28411186
[TBL] [Abstract][Full Text] [Related]
6. Experimental evolution of resistance to an antimicrobial peptide.
Perron GG; Zasloff M; Bell G
Proc Biol Sci; 2006 Jan; 273(1583):251-6. PubMed ID: 16555795
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A.
Hong RW; Shchepetov M; Weiser JN; Axelsen PH
Antimicrob Agents Chemother; 2003 Jan; 47(1):1-6. PubMed ID: 12499161
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Ceragenins in Controlling the Growth of Oral Microorganisms: Implications for Oral Hygiene Management.
Czarnowski M; Słowińska M; Sawieljew M; Wnorowska U; Daniluk T; Król G; Karasiński M; Okła S; Savage PB; Piktel E; Bucki R
Pharmaceuticals (Basel); 2024 Feb; 17(2):. PubMed ID: 38399419
[TBL] [Abstract][Full Text] [Related]
9. Silver and Antimicrobial Polymer Nanocomplexes to Enhance Biocidal Effects.
Pereira D; Ferreira S; Ramírez-Rodríguez GB; Alves N; Sousa Â; Valente JFA
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279254
[TBL] [Abstract][Full Text] [Related]
10. Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum.
Skłodowski K; Suprewicz Ł; Chmielewska-Deptuła SJ; Kaliniak S; Okła S; Zakrzewska M; Minarowski Ł; Mróz R; Daniluk T; Savage PB; Fiedoruk K; Bucki R
Front Microbiol; 2023; 14():1290952. PubMed ID: 38045035
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in membrane targeting antifungal agents to mitigate antifungal resistance.
Mehta D; Saini V; Bajaj A
RSC Med Chem; 2023 Sep; 14(9):1603-1628. PubMed ID: 37731690
[TBL] [Abstract][Full Text] [Related]
12. Glyoxylate Shunt and Pyruvate-to-Acetoin Shift Are Specific Stress Responses Induced by Colistin and Ceragenin CSA-13 in Enterobacter hormaechei ST89.
Prasad SV; Fiedoruk K; Zakrzewska M; Savage PB; Bucki R
Microbiol Spectr; 2023 Aug; 11(4):e0121523. PubMed ID: 37338344
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial and Antibiofilm Activities of Ceragenins Alone and in Combination with Levofloxacin Against Multidrug Resistant Myroides spp. Clinical Isolates from Patients with Urinary Tract Infections.
Oyardi O; Eltimur T; Demir ES; Alkan B; Savage PB; Akcali A; Bozkurt-Guzel C
Curr Microbiol; 2023 May; 80(6):210. PubMed ID: 37191731
[TBL] [Abstract][Full Text] [Related]
14. Investigation of α,ω-Disubstituted Polyamine-Cholic Acid Conjugates Identifies Hyodeoxycholic and Chenodeoxycholic Scaffolds as Non-Toxic, Potent Antimicrobials.
Sue K; Cadelis MM; Troia T; Rouvier F; Bourguet-Kondracki ML; Brunel JM; Copp BR
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830315
[TBL] [Abstract][Full Text] [Related]
15. Ceragenin CSA-44 as a Means to Control the Formation of the Biofilm on the Surface of Tooth and Composite Fillings.
Tokajuk J; Deptuła P; Chmielewska SJ; Skłodowski K; Mierzejewska ŻA; Grądzka-Dahlke M; Tołstoj A; Daniluk T; Paprocka P; Savage PB; Bucki R
Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631012
[TBL] [Abstract][Full Text] [Related]
16. New β-Lactam Antibiotics and Ceragenins - A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of
Paprocka P; Durnaś B; Mańkowska A; Skłodowski K; Król G; Zakrzewska M; Czarnowski M; Kot P; Fortunka K; Góźdź S; Savage PB; Bucki R
Infect Drug Resist; 2021; 14():5681-5698. PubMed ID: 34992394
[TBL] [Abstract][Full Text] [Related]
17. Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents.
Skłodowski K; Chmielewska SJ; Depciuch J; Deptuła P; Piktel E; Daniluk T; Zakrzewska M; Czarnowski M; Cieśluk M; Durnaś B; Parlińska-Wojtan M; Savage PB; Bucki R
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834355
[TBL] [Abstract][Full Text] [Related]
18. Physiology and Physical Chemistry of Bile Acids.
di Gregorio MC; Cautela J; Galantini L
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579036
[TBL] [Abstract][Full Text] [Related]
19. NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.
Chmielewska SJ; Skłodowski K; Piktel E; Suprewicz Ł; Fiedoruk K; Daniluk T; Wolak P; Savage PB; Bucki R
Infect Drug Resist; 2020; 13():3277-3294. PubMed ID: 33061475
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells.
Piktel E; Markiewicz KH; Wilczewska AZ; Daniluk T; Chmielewska S; Niemirowicz-Laskowska K; Mystkowska J; Paprocka P; Savage PB; Bucki R
Int J Nanomedicine; 2020; 15():4573-4589. PubMed ID: 32606693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
